Innate immune reprogramming to overcome therapy resistance in high-risk colorectal cancer
Dauer: 36 Monate, Fördersumme: € 800.000
Decoding cellular senescence in glioblastoma (GlioAge)
Dauer: 36 Monate, Fördersumme: € 898.970
Precision medicine for breast cancer: multi-omics towards predicting complete remission and avoiding surgery
Dauer: 48 Monate, Fördersumme: € 899.630
PIMIENTO PrecIsion Medicine in IntravENTricular hemorrhage for Outcome prediction
Dauer: 36 Monate, Fördersumme: € 865.350
Genomics-based immunological risk stratification in kidney transplantation
Dauer: 36 Monate, Fördersumme: € 899.840
Combating Viral Susceptibility in Premature Infants
Dauer: 36 Monate, Fördersumme: € 738.030